Post-graduate degree, including the integrated PG degree in Biochemistry, Microbiology or Biotechnology. Development of Innovative Diagnostics for Fungal Diseases in India, Addressing a Neglected Public Health Concern.
One of the major changes is the reduction in approval timelines. The time limit for granting permissions related to clinical trials, bioavailability, and bioequivalence studies has been cut from 90 working days to 45 working days.
To support our growth plans, we are seeking young, skilled professionals with experience in parenteral/injectable formulations for our manufacturing facility in Ahmedabad, Gujarat
Diploma in Pharmacy (D-Pharma) from any institute approved by Pharmacy Council on India (PCI) / AICTE. Persons holding Bachelor in Pharmacy (B-Pharma) and Masters in Pharma(M- Pharma) from any Institute approved by Pharmacy Council of India (PCI)/AICTE will be given additional marks.
M.Sc. / M.Tech (Zoology / Medical or Human Genetics / Biochemistry/ Molecular Biology/ Botany / Microbiology / Biotechnology / Life Sciences / Applied Biology/Cytogenetics). Candidates should have a minimum six months experience in Cytogenetics or Molecular techniques.
Contribute to capacity-building initiatives, knowledge-sharing platforms, and policy development. Operate under the strategic guidance of the CEO and engage with multi-stakeholder, cross-cutting national programs. Educational
Master’s Degree in Life Sciences ; Doctoral Degree in Science from a recognised university or equivalent in Stem cell biology, Developmental biology, Cell biology, and / or Molecular Biology.
Masters in Organic Chemistry with 1-2 years of experience in the CRO Industry Strong organisational, project management and problem-solving skills with impeccable multi-tasking abilities.
The role holder is responsible for supervising and executing the manufacturing operations for Compression, Encapsulation, Coating, and Packing sections in a highly regulated pharmaceutical environment.
The U.S. Food and Drug Administration (FDA) has issued an official warning letter to Genetrace, a company based in Blaine, Washington, for offering an HIV diagnostic self-collection kit to U.S. customers without proper authorization.
According to the FDA, the product in question is a dried blood spot (DBS) card self-collection kit that people use at home to collect blood samples and send them to a lab for HIV testing. The agency says this kit qualifies as a medical device because it is meant to help diagnose disease.
Wockhardt has taken a major step in global healthcare by filing a Marketing Authorisation Application with the European Medicines Agency, EMA for its new antibiotic WCK 5222
Indian pharmaceutical major Lupin Limited has entered into a licensing and supply agreement with Spain-based Galenicum Health, S.L.U. to expand the global availability of injectable Semaglutide, a key GLP-1 receptor agonist used in the treatment of Type 2 diabetes and obesity.
Indias pharmaceutical exports increased to USD 23.1 billion during April–December 2025–26, up from USD 21.7 billion in the corresponding period of the previous fiscal, reflecting steady demand for Indian medicines in global markets.
B.Pharma / M.Pharma from a recognised University. Must be computer-Literate, proficient in using MS Office and able to handle IT enabled quality assurance module.